LENZ THERAPEUTICS INC (LENZ:NASDAQ)
$3.145 -0.015 (-0.4747%)
Analysed LENZ THERAPEUTICS INC (LENZ:NASDAQ) News Sources
LENZ Therapeutics Announces Everest Medicines Acquired Rights to Develop and Commercialize VIZZ® (LNZ100) in Greater China
07-06-2026
yahoo.com
LENZ Therapeutics adds China partner for presbyopia drug VIZZ
08-06-2026
proactiveinvestors.com
LENZ Therapeutics and Arrotex Pharmaceuticals Announce Exclusive License and Commercialization Agreement for VIZZ™ in Australia and New Zealand
24-06-2026
yahoo.com
LENZ Therapeutics Announces Launch of New Telehealth Prescribing Option to Accelerate Patient Access to VIZZ® for the Treatment of Presbyopia
06-07-2026
yahoo.com
Earnings Preview: LENZ Therapeutics, Inc. (LENZ) Q2 Earnings Expected to Decline
22-07-2026
yahoo.com
LENZ Therapeutics Q2 Earnings Call Highlights
11-08-2026
marketbeat.com
LENZ Therapeutics Inc (LENZ) (Q2 2026) Earnings Call Highlights: VIZZ Launch Momentum ...
12-08-2026
yahoo.com
LENZ Therapeutics (LENZ) Stock Sees Fair Value Moves Lower After Analyst Target Cuts
15-08-2026
yahoo.com
LENZ Therapeutics (LENZ) Stock Fair Value Falls After Analysts Cut VIZZ Launch Expectations
21-10-2026
yahoo.com
LENZ Therapeutics to Report Third Quarter 2026 Financial Results on October 29, 2026
22-10-2026
yahoo.com
What is the current price of LENZ THERAPEUTICS INC (LENZ:NASDAQ)?
The current price of LENZ THERAPEUTICS INC (LENZ:NASDAQ) is $3.145.
LENZ THERAPEUTICS INC (LENZ:NASDAQ) absolute price change since previous trading day?
The absolute price change of LENZ THERAPEUTICS INC (LENZ:NASDAQ) since the previous trading day is $-0.015.
LENZ THERAPEUTICS INC (LENZ:NASDAQ) percentage price change since previous trading day?
The percentage price change of LENZ THERAPEUTICS INC (LENZ:NASDAQ) since the previous trading day is -0.4747%.
What is the most recent average sentiment score for LENZ THERAPEUTICS INC (LENZ:NASDAQ)?
The most recent average sentiment score for LENZ THERAPEUTICS INC (LENZ:NASDAQ) is 74 out of 100.
What is the most recent average sentiment for LENZ THERAPEUTICS INC (LENZ:NASDAQ)?
The most recent sentiment for LENZ THERAPEUTICS INC (LENZ:NASDAQ) is .
SEC-8K** Filing Available For LENZ THERAPEUTICS INC (LENZ:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.